|
|
Thomson Financial Business Description:
| The Group's principal activities are to discover, develop, manufacture and commercialize pharmaceutical products to treat patients with significant unmet medical needs. The products of the Group are Avastin, Rituxan, Herceptin, Tarceva, Nutropin and TNKase. The major customers of the Group are AmerisourceBergen, Corp, Cardinal Health Inc and McKesson Inc. The trademarks of the Group includes Activase(R), Avastin(R), Cathflo(R), Activase(R), Genentech(R), Herceptin(R), Lucentis(R), Nutropin(R), Nutropin AQ(R) and Nutropin AQ Pen(R), Pulmozyme(R), Raptiva(R) and TNKase(R). On 02-Aug-2007 the Group acquired Tanox Inc. The Group operates in the United States, Asia Pacific, Canada, Switzerland, Singapore and other countries. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Genentech, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
